Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, Tamil Nadu 600036, India; Department of Polymeric Medical Devices, Medical Devices Engineering, Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences & Technology, Thiruvananthapuram, Kerala 695011, India.
C.U. Shah College of Pharmacy, SNDT Women's University, Sir Vithaldas Thakersay, Santacruz West, Juhu, Mumbai, Maharashtra 400049, India.
Int J Biol Macromol. 2021 Feb 1;169:103-121. doi: 10.1016/j.ijbiomac.2020.12.083. Epub 2020 Dec 15.
One of the most promising pharmaceutical research areas is developing advanced delivery systems for controlled and sustained drug release. The drug delivery system (DDS) can be designed to strengthen the pharmacological and therapeutic characteristics of different medicines. Natural polymers have resolved numerous commencing hurdles, which hindered the clinical implementation of traditional DDS. The naturally derived polymers furnish various advantages such as biodegradability, biocompatibility, inexpensiveness, easy availability, and biologically identifiable moieties, which endorse cellular activity in contrast to synthetic polymers. Among them, chitosan has recently been in the spotlight for devising safe and efficient DDSs due to its superior properties such as minimal toxicity, bio-adhesion, stability, biodegradability, and biocompatibility. The primary amino group in chitosan shows exceptional qualities such as the rate of drug release, anti-microbial properties, the ability to cross-link with various polymers, and macrophage activation. This review intends to provide a glimpse into different practical utilization of chitosan as a drug carrier. The first segment of the review will give cognizance into the source of extraction and chitosan's remarkable properties. Further, we have endeavored to provide recent literature pertaining to chitosan applications in various drug delivery systems via different administration routes along with current patented chitosan formulations.
药物输送系统(DDS)可设计用于增强不同药物的药理学和治疗特性。天然聚合物解决了许多阻碍传统 DDS 临床应用的初始障碍。天然衍生聚合物具有生物降解性、生物相容性、廉价、易得和可识别的生物部分等各种优势,这些优势支持细胞活性,与合成聚合物形成对比。其中,壳聚糖由于其低毒性、生物黏附性、稳定性、生物降解性和生物相容性等优异特性,最近成为设计安全有效的 DDS 的焦点。壳聚糖中的伯氨基具有独特的性质,如药物释放速度、抗菌性能、与各种聚合物交联的能力以及巨噬细胞激活能力。
本综述旨在探讨壳聚糖作为药物载体的不同实际应用。综述的第一部分将介绍壳聚糖的提取来源和显著特性。此外,我们还努力提供了与不同给药途径相关的各种药物输送系统中壳聚糖应用的最新文献,以及当前的壳聚糖专利配方。